Longitudinal Changes in Antibody Responses and Adverse Reactions across Successive SARS-CoV-2 mRNA Vaccinations from Primary Series to JN.1-adapted Booster in Hospital Employees: A 4-Year Prospective Cohort Study
Naoki Tani(Osaka Gakuin University), Yong Chong, Nobuyuki Shimono, Tomonori Sato(Tohoku University), Takahiko Horiuchi(Fukuoka City Hospital), Hideyuki Ikematsu, Takeyuki Goto(Fukuoka City Hospital), Koichi Akashi(Kyushu University), Yukiko Harada(Fukuoka City Hospital)
Cited by 0
Related Papers
PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria
|Nature Communications|2012|599
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
|The Lancet|2014|436
MEIOSIN Directs the Switch from Mitosis to Meiosis in Mammalian Germ Cells
|Developmental Cell|2020|211